Lexaria Bioscience (LEXX) Current Assets (2011 - 2026)
Lexaria Bioscience (LEXX) posted Current Assets of $4.06 million for fiscal Q3 2026 (quarter ended May 31, 2026), down 30.0% from $5.81 million a year earlier and down 29.6% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Current Assets came in at $3.47 million, down 56.1% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
- In prior fiscal years, Lexaria Bioscience's Current Assets was $7.9 million in FY2024 (+267.1%), $2.15 million in FY2023 (-69.2%), $6.98 million in FY2022 (-43.9%) and $12.44 million in FY2021 (+546.1%).
- Quarterly Current Assets has run from a low of $2.15 million in fiscal Q4 2023 to a high of $12.44 million in fiscal Q4 2021 over five years.
- On a year-over-year basis, Current Assets has declined in each of the last five quarters, with growth averaging 43.8% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was fiscal Q1 2022, with growth of 733.6%; the weakest was fiscal Q4 2023, with a decline of 69.2%.
- According to Business Quant data, Current Assets for the three prior fiscal quarters was $5.77 million (Q2 2026), $5.36 million (Q1 2026) and $3.47 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Lexaria Bioscience | 3.39 Mn | -12.26 Mn | - | 4.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 4.06 Mn |
| Feb 28, 2026 | 5.77 Mn |
| Nov 30, 2025 | 5.36 Mn |
| Aug 31, 2025 | 3.47 Mn |
| May 31, 2025 | 5.81 Mn |
| Feb 28, 2025 | 7.72 Mn |
| Nov 30, 2024 | 8.83 Mn |
| Aug 31, 2024 | 7.90 Mn |
| May 31, 2024 | 9.09 Mn |
| Feb 29, 2024 | 5.42 Mn |
| Nov 30, 2023 | 2.69 Mn |
| Aug 31, 2023 | 2.15 Mn |
| May 31, 2023 | 4.24 Mn |
| Feb 28, 2023 | 4.00 Mn |
| Nov 30, 2022 | 5.36 Mn |
| Aug 31, 2022 | 6.98 Mn |
| May 31, 2022 | 8.29 Mn |
| Feb 28, 2022 | 10.57 Mn |
| Nov 30, 2021 | 10.90 Mn |
| Aug 31, 2021 | 12.44 Mn |
API Access
Lexaria Bioscience Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();